Stryker Corporation

SYK Healthcare Medical Devices

Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024.

Revenue
+7.64%
EPS
−12.4%
Free cash flow
−19.4%
Total debt
−10.0%

Quarter to September 2026, against a year earlier

324.26 10.82 −3.23%
Market cap
$127.6B
P/E
35.3×
Fwd P/E
24.6×
Dividend yield
1.05%
F-score
5/9
Altman Z
4.81
Beneish M
−2.62
Dividend safety
82/100

Stryker Corporation 10-K filed Feb 12, 2025

Fiscal year 2024 · Period ended Dec 31, 2024 · Filed · accepted 11:47 AM ET · Document on sec.gov · Filing index

Red flags

  • Impairment

    Stryker Corporation recorded a goodwill impairment of $456.0 million in fiscal 2024

    10-K filed · The filing · sec.gov

What changed

Item 7, Management’s Discussion and Analysis: no comparison — no earlier filing on file